For instance, Survivin silencing, mediated by EpCAM aptamer, can make BCSCs sensitive to doxorubicin, leading to the reversal of resistance, which indicates that this novel strategy is an effective method to reverse drug resistance in BC (Wang T. et al., 2015). The gene discussed is EPCAM; the disease is breast cancer.